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Endovascular treatment of iliocaval occlusion
caused by retroperitoneal fibrosis: Late results in
two cases
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We report two cases of iliocaval occlusion caused by retroperitoneal fibrosis; one presented acute symptoms and one
chronic. Both were treated by use of transluminal angioplasty and stenting with excellent clinical, hemodynamic, and
imaging results at 36 and 51 months. These cases confirm the benefit of endovascular techniques in the treatment of
nonmalignant obstructive disease of large veins, and specifically in the case of retroperitoneal fibrosis. (J Vasc Surg 2002;
36:849-52.)
Retroperitoneal fibrosis (RF) is a rare cause of venous
occlusion. Its treatment is mainly medical, but in some
cases surgical correction can be indicated.1 Over the past
several years, endoluminal techniques and especially stents
have opened new fields in the treatment of iliocaval occlu-
sions.2,3 We report two cases of iliocaval occlusions result-
ing from RF that were treated with use of angioplasty and
stenting.
CASE REPORTS
Case 1. In July 1997, a 66-year-old man was admitted for an
inferior vena cava (IVC) compression syndrome with edema of
both limbs and genital organs. He had a history of idiopathic RF
with right nephrectomy and JJ catheter in the left ureter (left
ureteral obstruction with hydronephrosis) in 1995; he was since
treated with prednisolone, 20 mg a day. At this time, slight edema
of both ankles was present. Duplex scanning showed dilation of
both limb deep veins. Iliocavography (Fig 1, A) demonstrated an
occlusion of both common iliac veins (CIVs) and of the IVC
associated with important collateral pathways through the presa-
cral network and mainly both ascending lumbar veins and the
paravertebral network. Computed tomographic (CT) scan con-
firmed the iliocavography finding and showed the RF (Fig 2, A).
He was classified as C3,SESAD6-7PO.
4
Percutaneous puncture of both common femoral veins pro-
vided access to an 11-French sheath on each side, and systemic
heparinization was given. Both the CIVs and IVC were dilated and
then stented: one 14-mm diameter, 64-mm long Wallstent (Bos-
ton Scientific-Schneider, Minneapolis, Minn) in the IVC and one
12-mm diameter, 38-mm long in each CIV, the right one overlap-
ping the origin of the left CIV. A completion phlebogram showed
an excellent result. Intravenous heparin therapy was given postop-
eratively and then relayed by fluindione for 9 months. Compres-
sion stockings were also prescribed.
An iliocavography performed 41 months later did not show
restenosis (Fig 1, B). The patient remained asymptomatic 51
months after the procedure, and the duplex scan confirmed the
patency of all veins. The last CT scan (49 months) showed regres-
sion of the RF that was limited to a tiny thickening of the retro-
peritoneal tissues (Fig 2, B), and the JJ catheter was then retrieved.
Case 2. In November 1998, a 68-year-old man was admitted
for acute left-limb deep venous thrombosis (pain and swelling of
the entire limb). He also complained of abdominal pain since 1
month. Duplex-scanning showed deep vein thrombosis extending
from the left popliteal to the left CIV. This condition was con-
firmed by CT scanning (Fig 3, A), which showed no extension to
the contralateral iliac or to the IVC. A retroperitoneal mass was
surrounding the vessels from the aortic to both iliac bifurcations
including the left ureter, which was dilated cephalad up to the renal
cavities; diagnosis of idiopathic RF was made.
Under general anesthesia, venous thrombectomy was per-
formed after systemic heparinization through a left femoral ap-
proach, and an arteriovenous fistula (AVF) was created between
the superficial femoral artery and the internal saphenous vein. A
perioperative phlebogram showed a nonopacified left CIV without
collateral pathways, despite thrombectomy (Fig 3, B). A 14-mm
diameter, 64-mm long Wallstent was inserted through an 11
French sheath and dilated with a 15-mm angioplasty catheter with
an excellent anatomic result. Ureteral dilation was treated by a JJ
catheter inserted through a left nephrostomy after ureteral balloon
dilation. Treatment by compression stocking, prednisolone 30 mg
a day, and fluindione (for 6 month) was introduced postoperatively
while the patient received intravenous heparin therapy. The AVF
was closed 6 weeks later.
An iliocavography was performed at 25 months and did not
show restenosis (Fig 3, C and D). To date, the patient remains
asymptomatic without restenosis or venous insufficiency after a
follow up of 36 months.
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DISCUSSION
RF, also called Ormond disease, is characterized by a
retroperitoneal fibrotic mass that can surround the retro-
peritoneal structures leading to obstructive complications.
It can be secondary to malignant tumor; excluding these
cases, 68% of RF are idiopathic.5 Its incidence was deter-
mined to be less than 1 case in 10,000.6 It can occur at any
age (peak incidence, between 40 and 60 years), especially in
men (sex ratio, 2-2.9 men per 1 woman).6,7 Its pathogen-
esis remains unknown, although it is highly correlated with
aortic atherosclerosis. RF leads mainly to ureteral compli-
cations, but also to vascular and nervous compression.
Symptomatic venous obstructions are very rare, occurring
in 2% of the cases.1
Compression stockings and steroids, or even immuno-
suppressive therapy, are the basis of the medical treatment.
Surgery can be performed either by direct (femoral or
iliocaval bypass)8 or extraanatomic (Palma procedure) re-
construction. Rhee et al1 found 17 cases of symptomatic
iliocaval obstruction caused by RF. Medical treatment was
provided to seven patients: one died, one became asymp-
tomatic, and four had chronic edema, associated with pain
in two. The outcome of the other patient was not recorded.
Four patients had venous bypass with good midterm re-
sults. On the other hand, all four patients who had venous
thrombectomy developed early rethrombosis; none had
associated endovascular procedure.
Many investigators have reported the use of endovas-
cular techniques in venous occlusive diseases: balloon an-
gioplasty and mainly endovascular stents led to a less inva-
sive approach. These techniques can be used directly or
after performance of thrombolysis or surgical thrombecto-
my2,3; in these last cases, they improve the patency by the
correction of persisting lesions. Neglen3 has reported 97%
Fig 1. Case 1 iliocavographies. A, The preoperative examination shows occlusions of both CIVs and of the IVC.
Important collateral pathways through the presacral network and mainly both ascending lumbar veins and paravertebral
network are seen. B, 41 months after surgery: patency of both CIVs and of the IVC with regression of the collateral pathways.
Fig 2. Case 1 CT scans. A, Preoperative: the IVC is not opacified
and important collateral pathways are seen (paravertebral net-
work). A fibrous mass is surrounding the retroperitoneal structures
(arrow). Note the presence of a JJ catheter in the left ureter. B, 51
months after surgery: regression of the retroperitoneal mass and of
the collateral pathways, patency of the IVC. The IVC stent and the
left ureter JJ catheter are seen.
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of technical success with primary, assisted primary, and
secondary permeability rates at one year of respectively
82%, 91%, and 92%. In our experience (15 patients), tech-
nical success was achieved in all patients and primary and
secondary patency rates of 86.6% and 93.3% respectively,
were noted after a mean follow-up of 23.5 months.2
Only one case of endovascular treatment of RF venous
complication has been reported to date by Vorwerk et al9:
the patient had a compression of the right external iliac vein
and the IVC treated percutaneously with self-expandable
stents. Four weeks later, recurrent edema was treated by
additional stenting of the IVC. An acute right iliac deep
venous thrombosis occurred 2 days later: hydrodynamic
thrombectomy and stenting were performed.
We report two cases with excellent clinical and angio-
graphic long-term results, despite the fact that we had to
treat completely occluded veins. We chose to use Wallstents
for endovascular treatment of large veins. The main advan-
tages of this self-expandable stent are its flexibility, elastic-
ity, and visibility. Flexibility is very important in iliocaval
veins to accommodate the vein curves, and avoiding kink-
ing at the stent extremities. Even if the expansile force of
this stent is relatively low, its elasticity represent an indis-
pensable quality; although compression of a balloon-ex-
pandable stent can provoke its deformation, self-expand-
able stents revert to their original shape. In our previous
experience of iliac vein stenting, a Palmaz stent (Johnson &
Johnson Interventional Systems, Warren, NJ) was crushed
in a pregnant woman, leading to rethrombosis of the left
iliac vein.2
CONCLUSION
Iliocaval obstructive complications of RF are rare and
can be treated effectively, either with surgical or endovas-
cular techniques. The latter provides excellent results with
use of less invasive procedures.
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